BioSpecifics Technologies Corp Stock News

Summers Value Partners recently released its Q2 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 1.8% for the first half of 2020, outperforming its benchmark, t

Nisa Investment Advisors LLC decreased its stake in Endo International PLC (NASDAQ:ENDP) (TSE:ENL) by 63.2% in the 2nd quarter, Holdings Channel.com reports. The fund owned 10,750 shares of the compan

Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Endo International plc (

BioSpecifics (BSTC) delivered earnings and revenue surprises of 320.00% and 89.47%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Shares of BioSpecifics Technologies (NASDAQ:BSTC) rose 2% in pre-market trading after the company reported Q2 results.Quarterly Results Earnings per share decreased 87.36% over the past year to $0.11,

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product markete

BioSpecifics (BSTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Endo International plc (NASDAQ:ENDP) Q2 2020 Earnings Conference Call August 06, 2020 7:00 AM ET Company Participants Laure Park – Senior Vice President of Investor Relations and Corporate Affairs B

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq:ANIP) today announced the appointments of Jeanne Thoma, President and Chief Executive Offic

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination...

Endo International (NASDAQ:ENDP) (TSE:ENL) is scheduled to be issuing its quarterly earnings data before the market opens on Wednesday, August 5th. Analysts expect the company to announce earnings of

Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flow continued to pour in,...

July turned out to be a mixed month for FDA approvals. Endo International PLC's (NASDAQ: ENDP) cellulite treatment, Osmotica Pharmaceuticals PLC's (NASDAQ: OSMT) eye...

BioSpecifics is an interesting microcap that licenses an injectable collagenase clostridium histolyticum (CCH) for multiple indications to partner Endo International.

Summers Value Partners is a boutique value manager that uses a focused, long-term approach to investing in areas of the market where most managers are unwilling or unable to participate.